After retreating from the bond process, Texas Biomed gets $10 million for infrastructure through ARPA
Despite vocal opposition from animal rights activists and others, city council voted Thursday to give $10 million to Texas Biomedical Research Institute for infrastructure improvements at its campus.
Texas Biomed pulls $11M bond project request after complaints over primate testing
Texas Biomed had requested money from the $1.2 billion bond program to improve infrastructure at its aging campus. But a citizen committee charged with recommending which projects should get funding received numerous public comments opposing the institute’s request, based on Texas Biomed’s use of primates for animal testing.
Belly fat removal surgery study shows remarkable results for patients with Type 2 diabetes
A partnership between UT Health San Antonio, University Health, and Texas Biomed is showing promising, if not remarkable, results from a new minimally invasive procedure aimed at improving the health of patients with Type 2 diabetes.
Pfizer, Texas Biomed see promising results in prototype vaccine
SAN ANTONIO – The early, yet incomplete results showing Pfizer’s COVID-19 vaccine was 90% effective in humans are similar to what Texas Biomed saw in macaque monkeys after being infected with the virus. “If we don’t use the vaccine, then what good is it?”Schlesinger said transparency is vital to help build the public’s trust. Pfizer announced the potential breakthrough a few days after the presidential election, during which talk of a vaccine became politically charged. “So, at face value, it’s coincidental that it’s happened around this time.”He said Pfizer had previously said it would have early results around this time. We need to have a cautionary tale here.”Related: Pfizer says COVID-19 vaccine is looking 90% effective
Predictions COVID-19 vaccine ready this fall unrealistic, Texas Biomed CEO says
SAN ANTONIO Predictions by the White House that a COVID-19 vaccine could be ready by mid-October, and possibly distributed weeks later, are being called unrealistic by Dr. Larry Schlesinger, Texas Biomed CEO. He should know since Texas Biomed is testing many of the therapies and vaccines being developed for pharmaceutical companies, as well as developing its own vaccines. He said fully completing the Phase 3 trials would provide the first data whether the vaccine is safe and effective. So that the public can be confident and comfortable that the vaccine they put in their arm is going to work and its not going to cause problems, Schlesinger said. RELATED: News of potential COVID-19 vaccine met with optimism, caution